Singleton L C, Connor T H
School of Public Health, University of Texas, Houston, USA.
Oncol Nurs Forum. 1999 Oct;26(9):1491-6.
PURPOSE/OBJECTIVES: To evaluate the permeability of chemotherapy gloves when using carmustine (BCNU), etoposide, and paclitaxel, which were selected based on their reported toxicity and unique solvent systems.
Thirteen brands of chemotherapy gloves and one brand of examination glove. Of the 14 glove types tested, 11 were made of latex, and 3 were made of nitrile.
Ten samples of each type of glove were evaluated using rigorous laboratory test conditions usually not encountered in normal usage. The thickness of the gloves was measured using a digital caliper. The glove material was secured over glass vials containing the drug solution and inverted in plastic cell wells containing a filter paper disc. After a two-hour exposure time, the filter paper discs were removed and analyzed for the presence of the drug.
Permeability (i.e., greater than or equal to 1% of the total amount of drug passing through the glove material.)
All 14 types of gloves tested were impermeable to BCNU at two hours of exposure. Only two gloves, the Ansell Perry EP glove and the U.S. Clinical Chemo Bloc T glove, were impermeable to all three drugs. The remaining 12 gloves all demonstrated some level of permeation with etoposide at two hours, although 9 of the gloves had only 1 of 10 samples that were permeable. In all cases, percent of permeation was less than 2% of the amount of the drug in the test solution. Thirteen gloves tested for paclitaxel permeability were impermeable at the two-hour time period.
The results of this study indicate that most of the chemotherapy gloves on the market are either impermeable or minimally permeable to these three chemotherapy drugs.
Because gloves are universally recognized as a means of personal protection when handling cancer chemotherapy drugs, selection of a glove that is impermeable would be an obvious choice for healthcare workers. Although the present study was a static, laboratory-based study that did not duplicate actual work practice conditions. It should offer some guidance in the selection of glove types when handling chemotherapy drugs.
目的/目标:评估使用卡莫司汀(BCNU)、依托泊苷和紫杉醇时化疗手套的渗透性,这些药物是根据其已报道的毒性和独特的溶剂系统挑选出来的。
13个品牌的化疗手套和1个品牌的检查手套。在测试的14种手套类型中,11种由乳胶制成,3种由腈制成。
每种手套类型取10个样本,在通常正常使用中不会遇到的严格实验室测试条件下进行评估。使用数字卡尺测量手套厚度。将手套材料固定在装有药物溶液的玻璃瓶上,并倒置在装有滤纸圆盘的塑料细胞培养板中。暴露两小时后,取出滤纸圆盘并分析药物的存在情况。
渗透性(即通过手套材料的药物总量大于或等于1%)。
在两小时的暴露时间内,所有14种测试手套对卡莫司汀均不渗透。只有两种手套,即安塞尔·佩里EP手套和美国临床化疗阻断T手套,对所有三种药物均不渗透。其余12种手套在两小时时对依托泊苷均表现出一定程度的渗透,尽管其中9种手套在10个样本中只有1个样本渗透。在所有情况下,渗透百分比均小于测试溶液中药物量的2%。13种测试紫杉醇渗透性的手套在两小时时间段内不渗透。
本研究结果表明,市场上大多数化疗手套对这三种化疗药物要么不渗透,要么渗透性极小。
由于手套被普遍认为是处理癌症化疗药物时的个人防护手段,对于医护人员来说,选择不渗透的手套将是一个显而易见的选择。尽管本研究是一项基于实验室的静态研究,并未复制实际工作实践条件。但它在处理化疗药物时手套类型的选择方面应能提供一些指导。